QuidelOrtho Inc. (QDEL) - Long-Term Liabilities to Capital

QuidelOrtho Inc. - graphic logo of issuer QDEL

QuidelOrtho (QDEL) is a key developer of rapid diagnostics, where customer lock-in to consumables allows for flexible management of test costs. Revenues are based on a massive installed base of systems, while growth is driven by the merger with Ortho and laboratory robotization. The environmental focus is directed toward reducing plastic and improving energy efficiency. This chart for the separate_debt_long_eq metric shows values at 1.43.

QuidelOrtho Corporation - QDEL Long-Term Debt to Capital (period 07/04/2022 - 10/29/2026)

Comprehensive metric breakdowns and analytics for QuidelOrtho (QDEL)

- stock value and consensus price forecast:
Stock Quotes Quidel Corporation|QDEL - Analyst Consensus Forecast
- market capitalization indicators:
Market Value QuidelOrtho Corporation|QDEL - Enterprise Value
- book value of equity indicators:
Equity per Share QuidelOrtho|QDEL - Book Capitalization|Market Capitalization to Book Value Ratio quidel.com|QDEL - Aggregate Company Assets
- debt and solvency information:
Debt to Equity Ratio QuidelOrtho|QDEL - Long-Term Debt to Capital|Short-Term Debt to Capital quidel.com|QDEL - Company Debts|Debt to Book Capitalization Ratio QuidelOrtho Corporation|QDEL - Company Long-Term Liabilities|Short-Term Debt QuidelOrtho
Comprehensive company analysis:Quidel Corporation
Product sample of QuidelOrtho

Risks of disruptions in global reagent and electronics supplies make QuidelOrtho (QDEL) dependent on financial stability during external shocks. GURU.Markets analysts utilize the long-term debt-to-equity ratio 1.43 to assess the proportion of loans with a maturity of over one year relative to equity, where a low level minimizes default risk, while moderate leverage stimulates business expansion.

Competing companies

Long-Term Debt to Equity Ratio Agilent Technologies, Inc. (A)|Long-Term Debt to Capital DGX|ILMN - Long-Term Liabilities to Capital|Long-Term Debt to Capital EXAS (Exact Sciences)|RVTY: Long-Term Debt to Capital Ratio|Bio-Rad - Long-Term Debt to Capital|NNNN - Long-Term Debt to Capital|Sterigenics (SHC) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio OPK|CDNA (CareDx Inc) - Long-Term Debt to Capital|Long-Term Debt to Capital maravai.com|Long-Term Debt to Equity Fulgent Genetics (FLGT)|Long-Term Debt to Equity LAB (Standard BioTools Inc)|Cytek Bio - Long-Term Debt to Equity Ratio|OraSure Corp (OSUR) - Long-Term Liabilities to Capital|XGN - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital mdxhealth.com MDXH|LUCD: Long-Term Debt to Capital|PRE - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity ProPhase Labs, Inc. (PRPH)|ainos.com (AIMD) - Long-Term Indebtedness to Equity|Co-Diagnostics - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Heart Test Laboratories, Inc. HSCS|Biomerica, Inc - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Cardio Diagnostics CDIO|VRAX: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio BJDX|AWH (Aspira Women's Health Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital Accelerate Diagnostics Inc. AXDX|Long-Term Debt to Equity CENTOGENE, N.V. (CNTG)|Long-Term Debt to Equity ENZ (enzo.com)|Long-Term Debt to Equity Fresh2 Group FRES|Genetic Technologies Ltd (GENE) - Long-Term Liabilities to Capital|ME - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient PMD (Psychemedics Corp.)